Yamaguchi Miki, Hirayama Fumiya, Wakamoto Shinobu, Fujihara Mitsuhiro, Murahashi Hideaki, Sato Norihiro, Ikebuchi Kenji, Sawada Ken-ichi, Koike Takao, Kuwabara Mikinori, Azuma Hiroshi, Ikeda Hisami
Hokkaido Red Cross Blood Center, Sapporo, Japan.
Transfusion. 2002 Jul;42(7):921-7. doi: 10.1046/j.1537-2995.2002.00149.x.
An ex vivo culture system was previously established for stem cell expansion using human marrow stromal cells and serum-free medium. However, the stromal cells were prepared using long-term culture medium containing horse serum and FCS, which may transmit infectious diseases of xenogeneic origin. In this study, therefore, a method was established to prepare stromal cells using an AB serum-based medium. In the case that serum from a transplant recipient or PBPC donor is available, additional infectious diseases would not be transmitted.
Cord blood CD34+ cells were cultured with thrombopoietin, stem cell factor, and flt3/flk2 ligand on a monolayer of human marrow primary stromal cells prepared using long-term culture medium or AB serum-based medium. After 2 weeks, clonogenic progenitor activity and SCID mouse-reconstituting cell activity were assayed. mRNA expression of cytokines and Notch ligand by stromal cells was also examined.
There were no remarkable differences in expansion-supporting activity and mRNA expression between stromal cells established by the two methods.
An ex vivo expansion system completely based on AB serum has been established.